Role of nitric oxide and peroxynitrite in the cytokine-induced sustained myocardial dysfunction in dogs in vivo

Journal of Clinical Investigation

Volumn 101, Issue 10, 1998, Pages 2207-2214

  Oyama, Jun Ichi ^a   Shimokawa, Hiroaki ^a   Momii, Hidetoshi ^a   Cheng, Xiao Shu ^a   Fukuyama, Naoto ^b   Arai, Yukinori ^a   Egashira, Kensuke ^a   Nakazawa, Hiroe ^b   Takeshita, Akira ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b TOKAI UNIVERSITY   (Japan)

Author keywords

Cardiac dysfunction; Cytokine; Interleukin 1 ; Nitric oxide; Peroxynitrite

Indexed keywords

3 NITROTYROSINE; AMINOGUANIDINE; CREATINE KINASE MB; CYTOKINE; DEXAMETHASONE; INTERLEUKIN 1BETA; MICROSPHERE; MYELOPEROXIDASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PEROXYNITRITE; TYROSINE; TYROSINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA PRESSURE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; CYTOKINE RELEASE; DOG; ECHOCARDIOGRAPHY; ENZYME ACTIVITY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART RATE; LEUKOCYTE COUNT; NONHUMAN; PRIORITY JOURNAL; STUNNED HEART MUSCLE;

EID: 0032523838     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI986     Document Type: Article

References (51)

1. De Belder, A.J., M.W. Radomski, H.J. Why, P.J. Richardson, and J.F. Martin. 1995. Myocardial calcium-independent nitric oxide synthase activity is present in dilated cardiomyopathy, myocarditis, and postpartum cardiomyopathy but not in ischaemic or valvular heart disease. Br. Heart J. 74:426-430.
2. Matsumori, A., T. Yamada, H. Suzuki, Y. Matoba, and S. Sasayama. 1994. Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br. Heart J. 72:561-566.
3. Yang, X., N. Chowdhury, B. Cai, J. Brett, C. Marboe, R.R. Sciacca, and R.E. Michler. 1994. Induction of myocardial nitric oxide synthase by cardiac allograft rejection. J. Clin. Invest. 94:714-721.
4. Ross, R. 1993. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:801-809.
5. Munro, J.M., and R.S. Cotran. 1988. Biology of disease. The pathogenesis of atherosclerosis: atherogenesis and inflammation. Lab. Invest. 58:249-261.
6. Hannson, G.K., L. Jonassan, P.S. Seifert, and S. Stemme. 1989. Immunomechanisms in atherosclerosis. Arteriosclerosis. 9:567-578.
7. Evans, H.G., M.J. Lewis, and A.M. Shah. 1993. Interleukin 1β modulates myocardial contraction via dexamethasone-sensitive production of nitric oxide. Cardiovasc. Res. 27:1486-1490.
8. Okusawa, S., J.A. Gelfand, T. Ikejima, R.J. Connolly, and C.A. Dinarello. 1988. Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. J. Clin. Invest. 81:1162-1172.
9. Shioi, T., A. Matsumori, and S. Sasayama. 1996. Persistent expression of cytokine in the chronic stage of viral myocarditis in mice. Circulation. 94:2930-2937.
10. Finkel, M.S., C.V. Oddis, T.D. Jacob, S.C. Watkins, B.G. Hattler, and R.L. Simmons. 1992. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science. 257:387-389.
11. Levine, B., J. Kalman, L. Mayer, H.M. Fillit, and M. Packer. 1990. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N. Engl. J. Med. 323:236-241.
12. Torre-Amione, G., S. Kapadia, J. Lee, J.-B. Durand, R.D. Bies, J.B. Young, and D.L. Mann. 1996. Tumor necrosis factor-α and tumor necrosis factor receptors in the failing human heart. Circulation. 93:704-711.
13. Pinsky, M.R., J.-L. Vincent, J. Deviere, M. Alegre, R.J. Kahn, and E. Dupont. 1943. Serum cytokine levels in human septic shock: relation to multiple-system organ failure and mortality. Chest. 103:565-575.
14. Balligand, J.-L., D. Ungureanu-Longrois, W.W. Simmons, D. Pimental, T.A. Malinski, M. Kapturczak, Z., Taha, C.J. Lowenstein, A.J. Davidoff, R.A. Kelly, et al. 1994. Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes. J. Biol. Chem. 269:27580-27588.
15. Tsujino, M., Y. Hirata, T. Imai, K. Kanno, S. Eguchi, H. Ito, and F. Marumo. 1994. Induction of nitric oxide synthase gene by interleukin 1β in cultured rat cardiocytes. Circulation. 90:375-383.
16. LaPointe, M.C., and J.R. Sitkins. 1996. Mechanisms of interleukin 1β regulation of nitric oxide synthase in cardiac myocytes. Hypertension. 27:709-714.
17. Hasan, K., B.-J. Heesen, J.A. Corbett, M.L. McDaniel, K. Chang, W. Allison, B.H. Wolffenbuttel, J.R. Williamson, and R.G. Tilton. 1993. Inhibition of nitric oxide formation by guanidines. Eur. J. Pharmacol. 249:101-106.
18. Misko, T.P., W.M. Moore, T.P. Kasten, G.A. Nickols, J.A. Corbett, R.G. Tilton, M.L. McDaniel, J.R. Williamson, and M.G. Currie. 1993. Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur. J. Pharmacol. 233:119-125.
19. Bradley, P.P., D.A. Priebat, R.D. Christensen, and G. Rothstein. 1982. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J. Invest. Dermatol. 78:206-209.
20. Ohnishi, M., H. Koike, N. Kawamura, S.J. Tojo, M. Hayashi, and S. Morooka. 1996. Role of P-selectin in the early stage of the Arthus reaction. Immunopharmacology. 34:161-170.
21. Huie, R.E., and S. Padmaja. 1993. The reaction of NO with superoxide. Free Radic. Res. Commun. 18:195-199.
22. Beckman, J.S., T.W. Beckman, J. Chen, P.A. Marshall, and B.A. Freeman. 1990. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA 87:1620-1624.
23. Ischiropoulos, H., L. Zhu, and J.S. Beckman. 1992. Peroxynitrite formation from macrophage-derived nitric oxide. Arch. Biochem. Biophys. 298:446-451.
24. Maruyama, W., Y. Hashizume, K. Matsumoto, and M. Naoi. 1996. Identification of 3-nitro-L-tyrosine, a product of nitric oxide and superoxide, as an indicator of oxidative stress in the human brain. J. Chromatogr. B Biomed. Appl. 676:153-158.
25. Tsugita, A., and J.J. Scheffler. 1982. A rapid method for acid hydrolysis of protein with a mixture of trifluoroacetic acid and hydrochloric acid. Eur. J. Biochem. 124:585-588.
26. Petros, A., D. Bennett, and P. Vallance. 1991. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet. 338:1557-1558.
27. Momii, H., H. Shimokawa, J. Oyama, and X.S. Cheng. 1998. Inhibition of adhesion molecules prevents cytokine-induced sustained myocardial dysfunction. J. Mol. Cell. Cardiol. In press. (Abstr.)
28. Cheng, X.S., H. Shimokawa, H. Momii, and J. Oyama. 1997. Role of superoxide anion in the pathogenesis of cytokine-induced myocardial dysfunction in dogs in vivo. Circulation. 96(Suppl.):I605. (Abstr.)
29. +-independent nitric oxide synthase in the myocardium. Br. J. Pharmacol. 105:575-580.
30. Rimele, T.J., R.J. Sturm, L.M. Adams, D.E. Henry, R.J. Heaslip, B.M. Weichman, and D. Grimes. 1988. Interaction of neutrophils with vascular smooth muscle: identification of a neutrophil-derived relaxing factor. J. Pharmacol. Exp. Ther. 245:102-111.
31. Lorsbach, R.B., W.J. Murphy, C.J. Lowenstein, S.H. Snyder, and S.W. Russel. 1993. Expression of the nitric oxide synthase gene in mouse macrophages activated for tumor cell killing. J. Biol. Chem. 268:1908-1913.
32. Shindo, T., U. Ikeda, F. Ohkawa, Y. Kawahara, M. Yokoyama, and K. Shimada. 1995. Nitric oxide synthesis in cardiac myocytes and fibroblasts by inflammatory cytokines. Cardiovasc. Res. 29:813-819.
33. Balligand, J.-L., D. Ungureanu, R.A. Kelly, L. Kobzik, D. Pimental, T. Michel, and T.W. Smith. 1993. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J. Clin. Invest. 91:2314-2319.
34. Brady, A.J.B., P.A. Poole-Wilson, S.E. Harding, and J.B. Warren. 1992. Nitric oxide production with cardiac myocytes reduces their contractility in endotoxemia. Am. J. Physiol. 263:H1963-H1966.
35. Brady, A.J.B., J.B. Warren, P.A. Poole-Wilson, T.J. Williams, and S.E. Harding. 1993. Nitric oxide attenuates cardiac myocyte contraction. Am. J. Physiol. 265:H176-H182.
36. Herbertson, M.J., H.A. Werner, and K.R. Walley. 1996. Nitric oxide synthase inhibition partially prevents decreased LV contractility during endotoxemia. Am. J. Physiol. 270:H1979-H1984.
37. Li, Y., A. Ferrante, and D.P. Harvey. 1996. Neutrophil oxygen radical generation: synergistic responses to tumor necrosis factor and mono/polyunsaturated fatty acids. J. Clin. Invest. 97:1605-1609.
38. Balligand, J.L., R.A. Kelly, P.A. Marsden, T.W. Smith, and T. Michel. 1993. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc. Natl. Acad. Sci. USA. 90:347-351.
39. Kinugawa, K., O. Kohmoto, A. Yao, T. Serizawa, and T. Takahashi. 1997. Cardiac inducible nitric oxide synthase negatively modulates myocardial function in cultured rat myocytes. Am. J. Physiol. 272:H35-H47.
40. Beckman, J.S., and W.H. Koppenol. 1996. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am. J. Physiol. 27:C424-C437.
41. Ishida, H., K. Ichimori, Y. Hirota, M. Fukahori, and H. Nakazawa. 1996. Peroxynitrite-induced cardiac myocyte injury. Free Rad. Biol. Med. 20:343-350.
42. Castro, L., M. Rodriguez, and R. Radi. 1994. Aconitase is readily inactivated by peroxynitrite, but not by its precursor, nitric oxide. J. Biol. Chem. 269: 29409-29415.
43. Ames, B.N., R. Catheart, E. Schwiers, and P. Hochstein. 1981. Uric acid provides an antioxidant defense in humans against oxidant-and radical-caused aging and cancer: a hypothesis. Proc. Natl. Acad. Sci. USA. 78:6858-6862.
44. Gutteridge, J.M., R. Richmond, and B. Halliwell. 1979. Inhibition of the iron-catalyzed formation of hydroxyl radicals from superoxide and of lipid peroxidation by desferrioxamine. Biochem. J. 184:469-472.
45. Braunwald, E., and R. Kloner. 1982. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation. 66:1146-1149.
46. Engler, R., and J.W. Covell. 1987. Granulocytes cause reperfusion ventricular dysfunction after 15-minute ischemia in the dog. Circ. Res. 61:20-28.
47. Birdsall, H.H., D.M. Green, J. Trial, K.A. Youker, A.R. Burns, C.R. MacKay, G.J. LaRosa, H.K. Hawkins, C.W. Smith, L.H. Michael, et al. 1997. Complement C5a, TGF-β1, and MCP-1, in sequence, induce migration of monocytes into ischemic canine myocardium within the first one to five hours after reperfusion. Circulation. 95:684-692.
48. Myers, M.L., R. Bolli, R.F. Lekich, C.J. Hartley, and R. Roberts. 1985. Enhancement of recovery of myocardial function by oxygen free-radical scavengers after reversible regional ischemia. Circulation. 72:915-921.
49. Roberts, A.B., Y. Vodovotz, N.S. Roche, M.B. Sporn, and C.F. Nathan. 1992. Role of nitric oxide in antagonistic effects of transforming growth factor-β and interleukin 1β on the beating rate of cultured cardiac myocytes. Mol. Endocrinol. 6:1921-1930.
50. Guillen, I., M. Blanes, and J.V. Castell. 1995. Cytokine signaling during myocardial infarction: sequential appearance of IL-1 beta and IL-6. Am. J. Physiol. 269:R229-R235.
51. Tashiro, H., H. Shimokawa, K. Yamamoto, M. Nagano, M. Momohara, K. Muramatsu, and A. Takeshita. 1995. Monocyte-related cytokines in acute myocardial infarction. Am. Heart J. 130:446-452.